Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 248

1.

Respiratory syncytial virus infection enhances Pseudomonas aeruginosa biofilm growth through dysregulation of nutritional immunity.

Hendricks MR, Lashua LP, Fischer DK, Flitter BA, Eichinger KM, Durbin JE, Sarkar SN, Coyne CB, Empey KM, Bomberger JM.

Proc Natl Acad Sci U S A. 2016 Feb 9;113(6):1642-7. doi: 10.1073/pnas.1516979113. Epub 2016 Jan 4.

2.

Staphylococcus aureus Biofilm Growth on Cystic Fibrosis Airway Epithelial Cells Is Enhanced during Respiratory Syncytial Virus Coinfection.

Kiedrowski MR, Gaston JR, Kocak BR, Coburn SL, Lee S, Pilewski JM, Myerburg MM, Bomberger JM.

mSphere. 2018 Aug 15;3(4). pii: e00341-18. doi: 10.1128/mSphere.00341-18.

3.

The DeltaF508-CFTR mutation results in increased biofilm formation by Pseudomonas aeruginosa by increasing iron availability.

Moreau-Marquis S, Bomberger JM, Anderson GG, Swiatecka-Urban A, Ye S, O'Toole GA, Stanton BA.

Am J Physiol Lung Cell Mol Physiol. 2008 Jul;295(1):L25-37. doi: 10.1152/ajplung.00391.2007. Epub 2008 Mar 21.

4.

RSV mediates Pseudomonas aeruginosa binding to cystic fibrosis and normal epithelial cells.

Van Ewijk BE, Wolfs TF, Aerts PC, Van Kessel KP, Fleer A, Kimpen JL, Van der Ent CK.

Pediatr Res. 2007 Apr;61(4):398-403.

PMID:
17515861
5.

Cystic fibrosis and the war for iron at the host-pathogen battlefront.

Bouvier NM.

Proc Natl Acad Sci U S A. 2016 Feb 9;113(6):1480-2. doi: 10.1073/pnas.1525101113. Epub 2016 Jan 22. No abstract available.

6.

Tobramycin-Treated Pseudomonas aeruginosa PA14 Enhances Streptococcus constellatus 7155 Biofilm Formation in a Cystic Fibrosis Model System.

Price KE, Naimie AA, Griffin EF, Bay C, O'Toole GA.

J Bacteriol. 2015 Oct 19;198(2):237-47. doi: 10.1128/JB.00705-15. Print 2016 Jan 15.

7.
8.
9.

In vitro analysis of tobramycin-treated Pseudomonas aeruginosa biofilms on cystic fibrosis-derived airway epithelial cells.

Anderson GG, Moreau-Marquis S, Stanton BA, O'Toole GA.

Infect Immun. 2008 Apr;76(4):1423-33. doi: 10.1128/IAI.01373-07. Epub 2008 Jan 22.

10.

Respiratory syncytial virus infection facilitates acute colonization of Pseudomonas aeruginosa in mice.

de Vrankrijker AM, Wolfs TF, Ciofu O, Høiby N, van der Ent CK, Poulsen SS, Johansen HK.

J Med Virol. 2009 Dec;81(12):2096-103. doi: 10.1002/jmv.21623.

PMID:
19856469
11.

Rhinovirus infection liberates planktonic bacteria from biofilm and increases chemokine responses in cystic fibrosis airway epithelial cells.

Chattoraj SS, Ganesan S, Jones AM, Helm JM, Comstock AT, Bright-Thomas R, LiPuma JJ, Hershenson MB, Sajjan US.

Thorax. 2011 Apr;66(4):333-9. doi: 10.1136/thx.2010.151431. Epub 2011 Feb 2.

12.

A Survival Strategy for Pseudomonas aeruginosa That Uses Exopolysaccharides To Sequester and Store Iron To Stimulate Psl-Dependent Biofilm Formation.

Yu S, Wei Q, Zhao T, Guo Y, Ma LZ.

Appl Environ Microbiol. 2016 Oct 14;82(21):6403-6413. Print 2016 Nov 1.

13.

Engineered cationic antimicrobial peptide (eCAP) prevents Pseudomonas aeruginosa biofilm growth on airway epithelial cells.

Lashua LP, Melvin JA, Deslouches B, Pilewski JM, Montelaro RC, Bomberger JM.

J Antimicrob Chemother. 2016 Aug;71(8):2200-7. doi: 10.1093/jac/dkw143. Epub 2016 May 26.

14.

Conditions associated with the cystic fibrosis defect promote chronic Pseudomonas aeruginosa infection.

Staudinger BJ, Muller JF, Halldórsson S, Boles B, Angermeyer A, Nguyen D, Rosen H, Baldursson O, Gottfreðsson M, Guðmundsson GH, Singh PK.

Am J Respir Crit Care Med. 2014 Apr 1;189(7):812-24. doi: 10.1164/rccm.201312-2142OC.

15.

Bacterial cis-2-unsaturated fatty acids found in the cystic fibrosis airway modulate virulence and persistence of Pseudomonas aeruginosa.

Twomey KB, O'Connell OJ, McCarthy Y, Dow JM, O'Toole GA, Plant BJ, Ryan RP.

ISME J. 2012 May;6(5):939-50. doi: 10.1038/ismej.2011.167. Epub 2011 Dec 1.

16.

Pseudomonas aeruginosa chronic colonization in cystic fibrosis patients.

Murray TS, Egan M, Kazmierczak BI.

Curr Opin Pediatr. 2007 Feb;19(1):83-8. Review.

PMID:
17224667
17.

Mannitol Does Not Enhance Tobramycin Killing of Pseudomonas aeruginosa in a Cystic Fibrosis Model System of Biofilm Formation.

Price KE, Orazi G, Ruoff KL, Hebert WP, O'Toole GA, Mastoridis P.

PLoS One. 2015 Oct 27;10(10):e0141192. doi: 10.1371/journal.pone.0141192. eCollection 2015.

18.

Interspecific small molecule interactions between clinical isolates of Pseudomonas aeruginosa and Staphylococcus aureus from adult cystic fibrosis patients.

Fugère A, Lalonde Séguin D, Mitchell G, Déziel E, Dekimpe V, Cantin AM, Frost E, Malouin F.

PLoS One. 2014 Jan 23;9(1):e86705. doi: 10.1371/journal.pone.0086705. eCollection 2014.

19.

A commensal streptococcus hijacks a Pseudomonas aeruginosa exopolysaccharide to promote biofilm formation.

Scoffield JA, Duan D, Zhu F, Wu H.

PLoS Pathog. 2017 Apr 27;13(4):e1006300. doi: 10.1371/journal.ppat.1006300. eCollection 2017 Apr.

20.

In vitro modeling of respiratory syncytial virus infection of pediatric bronchial epithelium, the primary target of infection in vivo.

Villenave R, Thavagnanam S, Sarlang S, Parker J, Douglas I, Skibinski G, Heaney LG, McKaigue JP, Coyle PV, Shields MD, Power UF.

Proc Natl Acad Sci U S A. 2012 Mar 27;109(13):5040-5. doi: 10.1073/pnas.1110203109. Epub 2012 Mar 12.

Supplemental Content

Support Center